Biological markers predictive of anticancer response to insulin-like growth factor-1 receptor kinase inhibitors

Details for Australian Patent Application No. 2008307579 (hide)

Owner OSI Pharmaceuticals, Inc.

Inventors Buck, Elizabeth A.; Haley, John D.

Agent Spruson & Ferguson

Pub. Number AU-A-2008307579

PCT Pub. Number WO2009/045389

Priority 60/997,514 03.10.07 US

Filing date 29 September 2008

Wipo publication date 9 April 2009

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/045389 Priority application(s): WO2009/045389

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008307581-Irrigation tire

2008307576-N-substituted oxindoline derivatives as calcium channel blockers